Dalmasso and colleagues (Gastroenterology, 2008, PMID 18061177) reported that KPV is taken up through the di- and tripeptide transporter PepT1, which is normally expressed in the small intestine and induced in the colon during inflammation, and that uptake was associated with reduced NF-B activation in human epithelial and immune cell lines
Your progress is regularly assessed, with adjustments made to maintain a trajectory towards sustained success
Recommended Use Once-daily dosing, commonly in the morning Should be prescribed and monitored by a licensed healthcare provider Personalized dosing based on weight, metabolic health, and treatment goals Maximizing Effectiveness For optimal results, AOD-9604 should be combined with: A balanced, whole-food diet Regular physical activity Adequate sleep and stress management This synergy supports long-term fat loss and sustainable metabolic health
Modi et al., Effects of glucagon-like peptide-1 on the reproductive axis in healthy men
